A biotech company focusing on Selective Estrogen Receptor Degraders (CERDs) for breast cancer.
3 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Olema Pharmaceuticals in the last 30 days yet.
The 1 sources with the most insights about Olema Pharmaceuticals on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
The host is short the stock based on fundamental skepticism, noting its drug would be 'fifth or sixth' to market. Believes it could fade back to the $22 level despite strong recent buying pressure.
The speaker is actively shorting the stock, believing a recent rally was an unsustainable 'weird squeeze' and expects the price to decline.
The speaker is actively shorting the stock, calling it 'dog poo poo' and believes it is in a very crowded and competitive market. They see a potential price target of $12 for the day.
The host is short the stock based on fundamental skepticism, noting its drug would be 'fifth or sixth' to market. Believes it could fade back to the $22 level despite strong recent buying pressure.
The speaker is actively shorting the stock, believing a recent rally was an unsustainable 'weird squeeze' and expects the price to decline.
The speaker is actively shorting the stock, calling it 'dog poo poo' and believes it is in a very crowded and competitive market. They see a potential price target of $12 for the day.
Other assets that creators frequently mention in the same content as Olema Pharmaceuticals.
The most active sources covering Olema Pharmaceuticals (OLMA) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 3 AI-extracted insights about Olema Pharmaceuticals (OLMA) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Olema Pharmaceuticals (OLMA) most frequently also discuss PLTR, QBTS, IONQ, SRPT, BTQ. See the "Discussed alongside" section above for full asset pages.